Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Health state valuations from the general public using the visual analogue scale.

Gudex C, Dolan P, Kind P, Williams A.

Qual Life Res. 1996 Dec;5(6):521-31.

PMID:
8993098
2.

Quality-of-life valuations of advanced breast cancer by New Zealand women.

Milne RJ, Heaton-Brown KH, Hansen P, Thomas D, Harvey V, Cubitt A.

Pharmacoeconomics. 2006;24(3):281-92.

PMID:
16519549
3.

Re-scaling social preference data: implications for modelling.

Cleemput I, Kind P, Kesteloot K.

Eur J Health Econ. 2004 Dec;5(4):290-8.

PMID:
15759169
4.
5.

Inconsistency and health state valuations.

Dolan P, Kind P.

Soc Sci Med. 1996 Feb;42(4):609-15.

PMID:
8643985
6.

A comparison of scoring weights for the EuroQol derived from patients and the general public.

Polsky D, Willke RJ, Scott K, Schulman KA, Glick HA.

Health Econ. 2001 Jan;10(1):27-37.

PMID:
11180567
7.

The time trade-off method: results from a general population study.

Dolan P, Gudex C, Kind P, Williams A.

Health Econ. 1996 Mar-Apr;5(2):141-54.

PMID:
8733106
8.

[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].

Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ.

Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1574-8. Dutch.

PMID:
16038162
9.
10.

Valuing the health state 'tinnitus': differences between patients and the general public.

Happich M, von Lengerke T.

Hear Res. 2005 Sep;207(1-2):50-8.

PMID:
15919164
11.

Description and valuation of health-related quality of life among the general public in Japan by the EuroQol.

Hisashige A, Mikasa H, Katayama T.

J Med Invest. 1998 Aug;45(1-4):123-9.

PMID:
9864973
12.

A social preference valuations set for EQ-5D health states in Flanders, Belgium.

Cleemput I.

Eur J Health Econ. 2010 Apr;11(2):205-13. doi: 10.1007/s10198-009-0167-0. Epub 2009 Jul 7.

PMID:
19582490
13.

Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.

Yusof FA, Goh A, Azmi S.

Value Health. 2012 Jan-Feb;15(1 Suppl):S85-90. doi: 10.1016/j.jval.2011.11.024.

14.

Inconsistencies in TTO and VAS values for EQ-5D health states.

Lamers LM, Stalmeier PF, Krabbe PF, Busschbach JJ.

Med Decis Making. 2006 Mar-Apr;26(2):173-81.

PMID:
16525171
15.

[Health Status of the German population: results of a representative survey using the EuroQol questionnaire].

K├Ânig HH, Bernert S, Angermeyer MC.

Gesundheitswesen. 2005 Mar;67(3):173-82. German.

PMID:
15789280
16.
17.

Productivity costs in health-state valuations : does explicit instruction matter?

Krol M, Brouwer W, Sendi P.

Pharmacoeconomics. 2006;24(4):401-14.

PMID:
16605285
18.

Comparison of individual and group valuation of health state scenarios across communities in West Africa.

Akunne AF, Bridges JF, Sanon M, Sauerborn R.

Appl Health Econ Health Policy. 2006;5(4):261-8.

PMID:
17249842
19.

Inconsistent responses in three preference-elicitation methods for health states.

Badia X, Roset M, Herdman M.

Soc Sci Med. 1999 Oct;49(7):943-50.

PMID:
10468398
20.

The effect of past and present illness experience on the valuations of health states.

Kind P, Dolan P.

Med Care. 1995 Apr;33(4 Suppl):AS255-63.

PMID:
7723454

Supplemental Content

Support Center